× Close
Schedule an Appointment

SAOL Knee Osteoarthritis (OA) Phase 3 Treatment Trial 2026

Knee Pain Clinical Trial

This clinical study looks at the effectiveness of a treatment for knee osteoarthritis for subjects who have had pain for 6 months but have not responded to at lease 3 months of conservative treatment.

Principal Investigator – J. Scott Bainbridge, MD

Sub-Investigators – Drew Trainor, DO; Susie Estes, NP; Michelle Hogue, NP; Jeremy Smith, PA

Research Administration and Coordination: Josephine Kubik, CCRC; Jake Feller

Josephine@DenverPainInstitute.com; Jake@DenverPainInstitute.com; 303-327-5511 ext. 319

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 Injectable for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee

Study details: SAOL Phase 3 Clinical RCT (https://clinicaltrials.gov/study/NCT07226258)